GlassScriptPhysician profile
Michael Keith Mclean
NPI 1831276468
$17,670.01
in general payments reported to CMS, 2019-2025
12 companies · $90.05 in 2025
The $90.05 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $16.59 · 2021: $12K · 2022: $17.08 · 2023: $4,636 · 2024: $317 · 2025: $90.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $4,789 · Food and Beverage: $253.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $4,789.41 |
| Food and Beverage | $253.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech, INC. | $12,400.00 | 2021 | |
| Medtronic, INC. | $4,826.01 | 2023-2024 | Venaseal |
| Medtronic Vascular, INC. | $117.37 | 2019 | |
| Atricure, INC. | $88.91 | 2024-2025 | Atriclip Laa Exclusion System, Synergy Ablation System |
| Davol INC. | $76.20 | 2021 | |
| Abbott Laboratories | $59.75 | 2020-2025 | Epic, Jot Dx |
| Chiesi USA, INC. | $19.37 | 2023 | Cleviprex, Kengreal |
| Kls-Martin L.P. | $19.28 | 2024 | |
| Becton, Dickinson and Company | $17.80 | 2024 | Progel Applicator Spray Tips |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.08 | 2022 | |
| Edwards Lifesciences Corporation | $15.11 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Boston Scientific Corporation | $13.13 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mclean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.